Global /China /Healthcare /Medical Distribution /1099
chevron_leftBack

Sinopharm Group Co. Ltd.

1099
SHEK: 1099 Delayed
17.86HKD -0.7%
2.30 USD
As of 24 April 2025, Sinopharm Group Co. Ltd. has a market cap of $7.18B USD, ranking #2191 globally and #302 in China. It ranks #192 in the Healthcare sector, and #7 in the Medical Distribution industry.
Global Rank
2191
Country Rank
302
Sector Rank
192
Industry Rank
7
Key Stats
Market Cap
$7.18BUSD
55.73B HKD
Enterprise Value
$16.77BUSD
130.1B HKD
Revenue (TTM)
$80.16BUSD
622.02B HKD
EBITDA (TTM)
$2.77BUSD
21.47B HKD
Net Income (TTM)
$966.82MUSD
7.5B HKD
EBITDA Margin
3.5%
Profit Margin
1.2%
PE Ratio
7.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Distribution
CEO
Wanyong Lian open_in_new
Employees
108,217
Founded
2003
Website
sinopharmgroup.com.cn open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.7% 1.5% -7.8% -12% -12% -15%
Upcoming Earnings
Earnings Date
Fri, Apr 25 Tomorrow

Markets

Exchange Ticker Price
Hong Kong Stock Exchange
MIC: XHKG
PRIMARY
1099
国药控股股份有限公司
ISIN: CNE100000FN7
Shares Out.:
1.342B1 Shares Float: 1.339B2
TV:
SA:
YF:
GF:
BA:
MS:
17.86 HKD
OTC Markets
MIC: OTCM
SHTDF
国药控股股份有限公司
ISIN: CNE100000FN7
Shares Out.:
1.342B1 Shares Float: 1.339B2
TV:
SA:
YF:
GF:
BA:
MS:
2.15 USD
OTC Markets
MIC: OTCM
SHTDY
国药控股股份有限公司 ADR
ISIN: US82937K1016
TV:
SA:
YF:
GF:
BA:
MS:
11.62 USD
Frankfurt Stock Exchange
MIC: XFRA
X2S
国药控股股份有限公司
ISIN: CNE100000FN7
TV:
SA:
YF:
GF:
BA:
X2S
MS:
1.96 EUR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Sinopharm Group Co. Ltd.

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People’s Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People’s Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Similar Companies

Industry: Medical Distribution (China)
Name
Market Cap diff.
Shanghai Pharmaceuticals Holding Co., Ltd.
601607
$8.27B
60.23B CNY
15%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Ltd.
600332
$5.51B
40.14B CNY
-23%
Jointown Pharmaceutical Group Co., Ltd.
600998
$3.3B
24.02B CNY
-54%
China National Medicines Corporation Ltd.
600511
$3.05B
22.23B CNY
-58%
China Meheco Group Co., Ltd.
600056
$2.08B
15.14B CNY
-71%
Industry: Medical Distribution (Global)
Name
Market Cap diff.
McKesson Corp.
MCK
$86.84B
1K%
Cencora, Inc.
COR
$55.21B
669%
Cardinal Health, Inc.
CAH
$32.48B
352%
SIGMA HEALTHCARE Ltd.
SIG
$21.56B
33.88B AUD
200%
Henry Schein, Inc.
HSIC
$8.02B
12%